Llwytho...
Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19
[Image: see text] There is urgent therapeutic need for COVID-19, a disease for which there are currently no widely effective approved treatments and the emergency use authorized drugs do not result in significant and widespread patient improvement. The food and drug administration-approved drug iver...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | ACS Pharmacol Transl Sci |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American
Chemical Society
2020
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724756/ https://ncbi.nlm.nih.gov/pubmed/33330844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00179 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|